CHMFL-ABL-039
作者：齊岳
發(fā)布時間：2023-08-23
09:21:26
點擊數(shù)：
產(chǎn)品名稱：CHMFL-ABL-039
產(chǎn)品描述：
| 產(chǎn)品描述 | CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia. |
| 靶點活性 | ABL V299L mutant:(kd)228 nM , Bcr-Abl:27.9 nM , ABL kinase:7.9 nM |
| 體外活性 | CHMFL-ABL-039 (0.01-3 μM; 4 hours) can dose-dependently inhibit the ABL Y245 phosphorylation and the subsequent downstream signaling mediators. CHMFL-ABL-039 (0-10 μM; 72 hours) is 6-10 fold more sensitive than Imatinib to BCR-ABL driven cancer cell lines, and BCR-ABL independent cell lines display a great selectivity window comparing to BCR-ABL driven cancer cell lines[1]. |
| 體內(nèi)活性 | CHMFL-ABL-039 (0.01-3 μM; 4 hours) can dose-dependently inhibit the ABL Y245 phosphorylation and the subsequent downstream signaling mediators. CHMFL-ABL-039 (0-10 μM; 72 hours) is 6-10 fold more sensitive than Imatinib to BCR-ABL drove cancer cell lines, and BCR-ABL independent cell lines display a great selectivity window comparing to BCR-ABL drove cancer cell lines[1]. |
| 分子量 | 594.63 |
| 分子式 | C31H33F3N6O3 |
| CAS No. | 2304344-56-5 |
存儲
| Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
DMSO: 55 mg/mL (92.49 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
聯(lián)系我們：
郵箱：2519696869@qq.com
QQ: 2519696869
電話：18066853083
微信：18066853083
公司介紹：
西安齊岳生物科技有限公司是集化學科研和定制與一體的高科技化學公司。業(yè)務范圍包括化學試劑和產(chǎn)品的研發(fā)、生產(chǎn)、銷售等。涉及產(chǎn)品為通用試劑的分銷、非通用試劑的定制與研發(fā)，涵蓋生物科技、化學品、中間體和化工材料等領域。
主營產(chǎn)品：COF、MOF單體系列：三蝶烯衍生物、金剛烷衍生物、四苯甲烷衍生物、peg、上轉(zhuǎn)換、石墨烯、光電材料、點擊化學、凝集素、載玻片、蛋白質(zhì)交聯(lián)劑、脂質(zhì)體、蛋白、多肽、氨基酸、糖化學等。
